Preventive Mastectomy (cont.)
8. Where can a person find more information about breast implants?
The U.S. Food and Drug Administration (FDA) regulates the use of breast
implants and can supply detailed information about these devices. To listen to
recorded information or request free printed material on breast implants,
consumers can contact the FDA Center for Devices and Radiological Health (CDRH)
Address: Consumer Staff
1350 Piccard Drive
Telephone: 1-888-INFO-FDA (1-888-463-6332), toll-free
between 8:00 a.m. and 4:30 p.m., Eastern Standard Time, for either number.)
Web site: http://www.fda.gov/cdrh/consumer/index.html
(Breast Implants Home Page)
Singletary SE. Techniques in surgery: Therapeutic and prophylactic
mastectomy. In: Harris JR, Lippman ME, Morrow M, Osborn CK, editors. Diseases of
the Breast. 3rd ed. Philadelphia: Lippincott Williams and Wilkins, 2004.
Sherry RM. Cancer prevention: Role of surgery in cancer prevention. In:
DeVita VT Jr., Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice
of Oncology. Vol. 1 and 2. 6th ed. Philadelphia: Lippincott Williams and
Dickson RB, Lippman ME. Cancer of the breast. In: DeVita VT Jr., Hellman S,
Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. Vol. 1 and
2. 6th ed. Philadelphia: Lippincott Williams and Wilkins, 2001.
Sakorafas GH. Women at high risk for breast cancer: Preventive strategies.
The Mount Sinai Journal of Medicine 2002; 69(4):264-266.
Taucher S, Gnant M, Jakesz R. Preventive mastectomy in patients at breast
cancer risk due to genetic alterations in the BRCA1 and BRCA2 gene. Langenbeck's
Archives of Surgery 2003; 388(1):3-8.
Anderson BO. Prophylactic surgery to reduce breast cancer risk: A brief
literature review. The Breast Journal 2001; 7(5):321-330.
Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic
mastectomy in women with a family history of breast cancer. The New England
Journal of Medicine 1999; 340(2):77-84.
Keefe KA, Meyskens FL Jr. Cancer prevention. In: Abeloff MD, Armitage JO,
Lichter AS, Niederhuber JE, editors. Clinical Oncology. 2nd ed. London:
Churchill Livingstone, 2000.
Levine DA, Gemignani ML. Prophylactic surgery in hereditary breast/ovarian
cancer syndrome. Oncology 2003; 17(7):932-941.
Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for the prevention of
breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel
Project P-1 Study. Journal of the National Cancer Institute 2005;
Vogel VG, Costantino JP, Wickerham DL, et al. Effects of tamoxifen vs
raloxifene on the risk of developing invasive breast cancer and other disease
outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial. Journal
of the American Medical Association 2006; 295(23):2727-2741.
Monteiro M. Physical therapy implications following the TRAM procedure.
Physical Therapy 1997; 77(7):765-770.
Source: U.S. National Institutes of Health, National Cancer Institute, http://www.cancer.govLast Editorial Review: 6/6/2008
Viewers share their comments
Preventive Mastectomy - Experience
Question: Please describe your experience with mastectomy.
Preventive Mastectomy - Reconstruction
Question: Did you have breast reconstruction after undergoing preventive mastectomy?
Preventive Mastectomy - Breast Cancer
Question: Did you get breast cancer despite having a preventive mastectomy?
Preventive Mastectomy - Procedure
Question: What kind of preventive mastectomy procedure did you have, a total mastectomy or a subcutaneous mastectomy?